CropScience Analyst & Investor Days

Similar documents
Investor Conference Call

Q Analyst and Investor Briefing October 28, 2010

Spring Investor Conference Werner Wenning CFO and Member of the Board

Investor Conference Call

Q Analyst and Investor Briefing July 28, 2011

Investor Conference Call Q Results

Q Analyst and Investor Briefing April 29, 2009

Q Analyst and Investor Briefing October 27, 2009

Q Analyst and Investor Briefing July 31, 2012

Investor Conference Call

Investor Conference Call

of 5 01/08/ :58

Q Analyst and Investor Briefing February 26, 2010

Q Financial Summary for Investors and Analysts

Investor Conference Call

Bayer increases sales and earnings in the second quarter

Nordex SE Conference Call H Hamburg, 14/08/2012

Spring Investor Conference Financial Performance 2003

Cembrit Group Q Unaudited interim report

Interim Report Q4 FY 17

Fourth Quarter 2015 Performance Summary

Q Analyst and Investor Briefing March 3, 2009

Bayer boosts third-quarter earnings: operating result doubled

HALF-YEAR 2016 INVESTOR PRESENTATION

Q Results. Strong start in May 3, 2016

Investor Conference. London, August 6, First Half 2003 Results

Eng US. 14 July 2017

FY 2016 Financial Results. Milan March 1st 2017

News Release. Bayer: sales and EBIT at record levels. Financial and innovation targets for 2011 achieved

Investor Handout Q Results

Wacker Neuson Group Quarterly report Q3/2018. November 8, 2018, unaudited

Investor Conference Call FY/Q Results

KION Q3 UPDATE CALL Gordon Riske, CEO Thomas Toepfer, CFO Wiesbaden, 14 November 2013

Financial Targets through 2022: Focus on Value Creation

Second quarter Vestas Wind Systems A/S. Copenhagen, 17 August Classification: Public

Q Analyst and Investor Briefing February 28, 2018

BASF and LetterOne sign agreement to merge Wintershall and DEA. Selected Investor Relations Slides September 27, 2018

Investor News. Another record year for Bayer. Fiscal 2015:

2017 THIRD-QUARTER EARNINGS REVIEW October 24, 2017

H FINANCIAL RESULTS. Milan September 18 th, 2018

January March 2010 Conference Call. Georg Denoke Member of the Executive Board & CFO 4 May 2010

1Q Performance Summary

Annual Results GfK SE Analyst Call. March 18, GfK 2016 Analyst call March 18, 2016

Nilfisk Q3 Interim Report 2018 Webcast presentation November 14, 2018

Suzlon Energy Limited

July 26, 2017 LafargeHolcim Ltd 2015

HALF-YEAR REPORT ENDED 30 JUNE HelloFresh SE

H Results. July 26th 2018

First Half of 2015 Performance Summary

Eng US. Q1 Presentation April, 2015

Eng US. 9 February Q4 Presentation 2017

Investor News. Bayer: strong business momentum continues and portfolio transformation underway. Fiscal 2014:

Non-Deal Debt Investor Call. Dr. Marcus Schenck, Chief Financial Officer E.ON AG 04 April 2011

ITW Conference Call First Quarter 2013

Q2 Presentation July, 2011

Natura 2Q11 Earnings Results July, 22nd 2011

9M 2018 FINANCIAL RESULTS. Milan November 14 th, 2018

First Quarter 2016 Performance Summary

Half-year 2011 Results. July 29, 2011

Conference Call March 22, Build with passion

Financial Results FY 2009 VTG AG On a safe track to a sustainable future

Financial Results. for the year ended December 31, Masato Yoshikawa

Sika for lasting bonds. Report on the third quarter of 2005

Wacker Neuson SE Q3/18 Conference Call. Martin Lehner (CEO), Wilfried Trepels (CFO) November 8, 2018

2007 Revenue and Results. 2007: strong increase in results Strengthened growth momentum. February 15 th, 2008

Q Financial Summary for Investors and Analysts

This graph shows region specific transitions in global agrochemical markets for the 10 year period between 2007 and The scale of the global

Merck FY/Q Financial Summary for Investors and Analysts

Merck FY/Q Financial Summary for Investors and Analysts

Zumtobel Group. Q1 2012/13 results. September 5, September

Merck FY/Q Financial Summary for Investors and Analysts

Interim Results 9-month figures FY 14

Q4 Presentation February, 2012

H Results MTU Aero Engines Conference Call with Investors and Analysts August 1, 2011

News Release. Bayer: operating performance on track. Financial News Conference on fiscal 2010:

Second quarter Vestas Wind Systems A/S. Copenhagen, 18 August Classification: Public

Steady top line growth in a mixed market

Frankfurt European MidCap Event. February 12, 2019

Fourth Quarter 2016 Performance Summary

Analyst Conference Drägerwerk AG & Co. KGaA. March 7 th 2019

HelloFresh SE QUARTERLY STATEMENT Q QUARTERLY STATEMENT Q HelloFresh SE

INTERIM REPORT JULY 17 SECOND QUARTER 2014

Investor and Analyst Presentation. Results Q

Full-Year / Fourth Quarter 2010 Results

H1/Q Financial Results

Third Quarter 2015 Earnings Call October 29, 2015

Stockholders Newsletter

Third quarter Vestas Wind Systems A/S. Copenhagen, 9 November Classification: Public

Q RESULTS BRUSSELS, 23 JULY 2015 WOLFGANG M. NEUMANN, PRESIDENT & CEO KNUT KLEIVEN, DEPUTY PRESIDENT & CFO

H Financial Results. Milan July 28th, 2016

Tackling the challenges ahead

1H 2011 Results and Outlook

Course of Business and Economic Position

Charts on Q1 2017/18 Facts & Figures

SEMPERIT GROUP FY 2017 / Q INVESTOR PRESENTATION. Dr Martin Füllenbach, CEO Frank Gumbinger, CFO 16 March 2018

O&M in the Last Mile Ezentis manages, maintains and deploys infrastructure for telecommunications and utilities companies.

Merck KGaA, Darmstadt, Germany, Reports Organic Growth in all Four Businesses in Second Quarter

Investor Conference Call FY/Q Results

Announcement of Q Results

Third Quarter 2016 Performance Summary

Transcription:

CropScience Analyst & Investor Days September 5 & 6, 2005 Lyon, France CropScience Analyst & Investor Days Efficiency Improvement and Business Excellence September 5-6, 2005 Lyon, France Dr. Dirk Suwelack Member of the Board of Management Bayer CropScience 1

Forward Looking Statements This presentation contains forward-looking statements based on current assumptions and forecasts made by Bayer AG and Bayer CropScience AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the Bayer CropScience AG or our parent company, Bayer AG, and the estimates given here. These factors include those discussed in Bayer AG's public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Bayer AG's Form 20-F). Neither Bayer AG nor Bayer CropScience AG assume any liability whatsoever to update these forward-looking statements or to conform them to future events or developments. CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 3 Solid Performance in the First Half of 2005 Slight decline of external sales compared to previous year (-0.8 %), mainly caused in Q2 by - Drought conditions in parts of Southern Europe & Latin America - Difficult farm economy in Brazil Business in Northern Europe & North America very satisfactory Increase in underlying EBIT of +5 % compared to previous year, but lower than anticipated Shortfall in Brazil negatively impacted EBIT by some 35 million EBIT benefit of 67 million from cessation of Goodwill amortization CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 4 2

EBIT Increase Compared to Previous Year Jan-Jun 2004 Jan-Jun 2005 YOY (in %) Sales 3,374 3,348-0.8 EBITDA 897 863-3.8 EBITDA-Margin 26.6 % 25.8 % EBIT 538 576 +7.1 EBIT-Margin 15.9 % 17.2 % Special items (41) (34) EBIT underlying 579 610 +5.4 CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 5 Slight Sales Decline Mainly Due to Business Development in Brazil Sales Development H1 2005 vs. H1 2004 3,374-6 -78 +47 +11 3,348 Actual H1 2004 ForEx Volume Prices Portfolio Actual H1 2005 CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 6 3

EBIT Increase Compared to Previous Year Despite Negative Impact of Brazil Situation EBIT Development H1 2005 vs. H1 2004 + 67-35 538 + 7-1 576 Actual H1 2004 Special items* ForEx Goodwill Business** Actual H1 2005 * Special items: 2004 (+41) and 2005 (-34) ** incl. portfolio, accounts/receivables, cost, others CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 7 Net Cash Flow Increase Compared to H1 2004 Driven by Consistent Receivables Management Significant increase of Net Cash Flow ( 140 million) due to retention of payment terms against strong pressure from the market in particular in Brazil Increase in inventories compared to previous year mainly due to: Slow business development in Brazil and Southern Europe Preparation for Asian Rust in the US New product launches: CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 8 4

Efficiency Improvement Through the Challenge 2007 Initiative Efficiency Improvement from Challenge 2007 is achieved by various Initiatives General Administration (GA) Research & Development Industrial Operations Crop Protection / Regions Environmental Science & BioScience Some examples: Sourcing improvement in Industrial Operations in-sourcing and procurement savings Site rationalization and realization of process synergies in manufacturing Adapting R&D activities, organization & processes System consolidation & harmonization GA benchmark resulting in process optimization Reduction of external IT services, Human Resources services and consultancy CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 9 Cost Saving and Efficiency Initiatives to Support Earnings Growth Impact of our Cost Saving and Efficiency Improvement Programs 600 500 400 300 200 100 0-100 -200-300 2002 2003 2004 2005* Challenge 2007 Savings Integration Savings One Time Costs (Integration & Challenge 2007) Combination of two efficiency improvement initiatives to achieve significant savings Positive EBIT impact in 2005 of ~ 100 million expected Continued ramp-up of savings from Challenge 2007 initiative in the second half of 2005 - positive net contributions as of 2006 Integration: Annual net savings of ~ 500 million in 2005 expected to be achieved Challenge 2007: Annual net savings of ~ 200 million in 2007 targeted *estimates CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 10 5

Expectations for the Year 2005 Significant increase in underlying EBIT Sales anticipated to decline slightly vs. previous year, but important contribution from new active ingredient portfolio Gradual improvement of the situation in Brazil expected in H2 2005 Major part of one-time cost (Challenge 2007) accounted already savings expected to contribute to EBIT in H2 2005 CropScience Analyst & Investor Days Lyon / September 5-6, 2005 Slide 11 Your partner for growth 6